Frontiers in Oncology | Hematologic Malignancies

Mini Review

Published on 20 Aug 2021

Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities?

in Hematologic Malignancies

Romane Joudinaud
Thomas Boyer

Frontiers in Oncology

doi 10.3389/fonc.2021.730899

5,853 views
9 citations

Original Research

Published on 20 Aug 2021

The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells

in Hematologic Malignancies

Xiyuan Lu
Lina Han
Jonathan Busquets
Meghan Collins
Alessia Lodi
Joseph R. Marszalek
Marina Konopleva
Stefano Tiziani

Frontiers in Oncology

doi 10.3389/fonc.2021.686765

6,482 views
17 citations

Systematic Review

Published on 20 Aug 2021

Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis

in Hematologic Malignancies

Xue Yang
Dongjun Li
Yao Xie

Frontiers in Oncology

doi 10.3389/fonc.2021.717678

5,148 views
13 citations

Original Research

Published on 18 Aug 2021

How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome

in Hematologic Malignancies

Na Li
Ming Jiang
Wan-Chun Wu
Wen-Wen Wei
Li-Qun Zou

Frontiers in Oncology

doi 10.3389/fonc.2021.704962

3,260 views
14 citations

Original Research

Published on 18 Aug 2021

PD-1 and TIGIT Are Highly Co-Expressed on CD8+ T Cells in AML Patient Bone Marrow

in Hematologic Malignancies

Ling Xu
Lian Liu
Danlin Yao
Xiangbo Zeng
Yikai Zhang
Jing Lai
Jun Zhong
Xianfeng Zha
Runhui Zheng
Yuhong Lu

Frontiers in Oncology

doi 10.3389/fonc.2021.686156

6,708 views
40 citations

Review

Published on 18 Aug 2021

Recent Progress on Primary Central Nervous System Lymphoma—From Bench to Bedside

in Hematologic Malignancies

Liang Shao
Chengshi Xu
Huijing Wu
Muhammad Jamal
Shan Pan
Sirui Li
Fei Chen
Ding Yu
Kui Liu
Yongchang Wei

Frontiers in Oncology

doi 10.3389/fonc.2021.689843

12,822 views
16 citations

Original Research

Published on 18 Aug 2021

A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia

in Hematologic Malignancies

Qiuhua Zhu
Shimei Yang
Wenbin Zeng
Mingjie Li
Zebing Guan
Lanlan Zhou
Hong Wang
Yanan Liu
Yanmin Gao
Shiqiu Qiu

Frontiers in Oncology

doi 10.3389/fonc.2021.701539

10,403 views
26 citations

Editorial

Published on 17 Aug 2021

Editorial: Special Issue on Innovative Multi-Disciplinary Approaches for Precision Studies in Leukemia

in Hematologic Malignancies

Sandra Marmiroli
Xu Huang
Valentina Serafin
Alison M. Michie

Frontiers in Oncology

doi 10.3389/fonc.2021.744009

2,429 views

Original Research

Published on 17 Aug 2021

Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia With Biallelic CEBPA Mutations Based on a Multi-Gene Panel and Nomogram Model

in Hematologic Malignancies

Li-Xin Wu
Hao Jiang
Ying-Jun Chang
Ya-Lan Zhou
Jing Wang
Zi-Long Wang
Lei-Ming Cao
Jin-Lan Li
Qiu-Yu Sun
Shan-Bo Cao

Frontiers in Oncology

doi 10.3389/fonc.2021.706935

5,977 views
10 citations

Clinical Trial

Published on 16 Aug 2021

Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Jia Liu
Zhong-Xing Jiang
Xin-Sheng Xie
Ding-Ming Wan
Wei-Jie Cao
Meng Wang
Zhen-Zhen Liu
Zhen-Kun Dong
Hai-Qiong Wang
Run-Qing Lu

Frontiers in Oncology

doi 10.3389/fonc.2021.710545

5,509 views
17 citations

Brief Research Report

Published on 13 Aug 2021

Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients

in Hematologic Malignancies

Veronika Riebl
Sandra Maria Dold
Dagmar Wider
Marie Follo
Gabriele Ihorst
Johannes M. Waldschmidt
Johannes Jung
Michael Rassner
Christine Greil
Ralph Wäsch

Frontiers in Oncology

doi 10.3389/fonc.2021.708231

5,853 views
14 citations

Original Research

Published on 11 Aug 2021

Curcumin in Combination With Omacetaxine Suppress Lymphoma Cell Growth, Migration, Invasion, and Angiogenesis via Inhibition of VEGF/Akt Signaling Pathway

in Hematologic Malignancies

Yu Zhang
Jingjing Xiang
Ni Zhu
Hangping Ge
Xianfu Sheng
Shu Deng
Junfa Chen
Lihong Yu
Yan Zhou
Jianping Shen

Frontiers in Oncology

doi 10.3389/fonc.2021.656045

12,218 views
18 citations

Mini Review

Published on 11 Aug 2021

Clinical Applications of MicroRNAs in Acute Myeloid Leukemia: A Mini-Review

in Hematologic Malignancies

Bhavana Bhatnagar
Ramiro Garzon

Frontiers in Oncology

doi 10.3389/fonc.2021.679022

4,919 views
16 citations

Original Research

Published on 05 Aug 2021

The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation

in Hematologic Malignancies

Chang Hou
Lili Zhou
Menglu Yang
Shuhui Jiang
Hongjie Shen
Mingqing Zhu
Jia Chen
Miao Miao
Yang Xu
Depei Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.700234

4,064 views
9 citations

Original Research

Published on 04 Aug 2021

Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma

in Hematologic Malignancies

Ruimin Hong
Elaine Tan Su Yin
Linqin Wang
Xin Zhao
Linghui Zhou
Guangfa Wang
Mingming Zhang
Houli Zhao
Guoqing Wei
Yiyun Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.713577

7,054 views
48 citations

Original Research

Published on 04 Aug 2021

Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With Outcomes

in Hematologic Malignancies

Hussein A. Abbas
Vakul Mohanty
Ruiping Wang
Yuefan Huang
Shaoheng Liang
Feng Wang
Jianhua Zhang
Yihua Qiu
Chenyue W. Hu
Amina A. Qutub

Frontiers in Oncology

doi 10.3389/fonc.2021.705627

5,314 views
12 citations

Original Research

Published on 03 Aug 2021

A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups

in Hematologic Malignancies

Yuting Gao
Li Wei
Seok Jin Kim
Liang Wang
Yingzhi He
Yanfang Zheng
Luca Bertero
Alessia Pellerino
Paola Cassoni
Luca Tamagnone

Frontiers in Oncology

doi 10.3389/fonc.2021.696147

6,350 views
16 citations

Original Research

Published on 02 Aug 2021

Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Bianca J. Lee
Sharmila Mallya
Nuntana Dinglasan
Amos Fung
Tram Nguyen
Lee-or Herzog
Joshua Thao
Edward G. Lorenzana
David Wildes
Mallika Singh

Frontiers in Oncology

doi 10.3389/fonc.2021.673213

5,209 views
15 citations

Original Research

Published on 02 Aug 2021

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia

in Hematologic Malignancies

Fortunato Morabito
Giovanni Tripepi
Riccardo Moia
Anna Grazia Recchia
Paola Boggione
Francesca Romana Mauro
Sabrina Bossio
Graziella D’Arrigo
Enrica Antonia Martino
Ernesto Vigna

Frontiers in Oncology

doi 10.3389/fonc.2021.684621

10,551 views
11 citations

Original Research

Published on 30 Jul 2021

Intensive Debulking Chemotherapy Improves the Short-Term and Long-Term Efficacy of Anti-CD19-CAR-T in Refractory/Relapsed DLBCL With High Tumor Bulk

in Hematologic Malignancies

Cuicui Lyu
Rui Cui
Jia Wang
Nan Mou
Yanyu Jiang
Wei Li
Qi Deng

Frontiers in Oncology

doi 10.3389/fonc.2021.706087

6,492 views
15 citations

Case Report

Published on 28 Jul 2021

Leukemia With TCF3-ZNF384 Rearrangement as a Distinct Subtype of Disease With Distinct Treatments: Perspectives From A Case Report and Literature Review

in Hematologic Malignancies

Na Lin
Xiaojing Yan
Dali Cai
Lei Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.709036

8,532 views
11 citations

Original Research

Published on 28 Jul 2021

Circular RNA Protein Tyrosine Kinase 2 Promotes Cell Proliferation, Migration and Suppresses Apoptosis via Activating MicroRNA-638 Mediated MEK/ERK, WNT/β-Catenin Signaling Pathways in Multiple Myeloma

in Hematologic Malignancies

Fan Zhou
Dongjiao Wang
Nian Zhou
Haimin Chen
Haotian Shi
Rong Peng
Wei Wei
Lixia Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.648189

4,410 views
24 citations

Original Research

Published on 27 Jul 2021

Downregulation of miR-142a Contributes to the Enhanced Anti-Apoptotic Ability of Murine Chronic Myelogenous Leukemia Cells

in Hematologic Malignancies

Zhiwei Chen
Yinyin Xie
Dan Liu
Ping Liu
Fei Li
Zhanglin Zhang
Mengmeng Zhang
Xiaolin Wang
Yuanliang Zhang
Xiaojian Sun

Frontiers in Oncology

doi 10.3389/fonc.2021.718731

4,092 views
8 citations

Mini Review

Published on 26 Jul 2021

PHF6 Mutations in Hematologic Malignancies

in Hematologic Malignancies

Jason H. Kurzer
Olga K. Weinberg

Frontiers in Oncology

doi 10.3389/fonc.2021.704471

15,273 views
38 citations

2,074 articles

articles

Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities?

The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells

Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis

How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome

PD-1 and TIGIT Are Highly Co-Expressed on CD8+ T Cells in AML Patient Bone Marrow

Recent Progress on Primary Central Nervous System Lymphoma—From Bench to Bedside

A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia

Editorial: Special Issue on Innovative Multi-Disciplinary Approaches for Precision Studies in Leukemia

Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia With Biallelic CEBPA Mutations Based on a Multi-Gene Panel and Nomogram Model

Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia

Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients

Curcumin in Combination With Omacetaxine Suppress Lymphoma Cell Growth, Migration, Invasion, and Angiogenesis via Inhibition of VEGF/Akt Signaling Pathway

Clinical Applications of MicroRNAs in Acute Myeloid Leukemia: A Mini-Review

The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation

Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma

Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With Outcomes

A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups

Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia

Intensive Debulking Chemotherapy Improves the Short-Term and Long-Term Efficacy of Anti-CD19-CAR-T in Refractory/Relapsed DLBCL With High Tumor Bulk

Leukemia With TCF3-ZNF384 Rearrangement as a Distinct Subtype of Disease With Distinct Treatments: Perspectives From A Case Report and Literature Review

Circular RNA Protein Tyrosine Kinase 2 Promotes Cell Proliferation, Migration and Suppresses Apoptosis via Activating MicroRNA-638 Mediated MEK/ERK, WNT/β-Catenin Signaling Pathways in Multiple Myeloma

Downregulation of miR-142a Contributes to the Enhanced Anti-Apoptotic Ability of Murine Chronic Myelogenous Leukemia Cells

PHF6 Mutations in Hematologic Malignancies